Evidence map›Paper›PMID 37050149›Full record

ArticlePlants (Basel, Switzerland)2023

Toxicity and Anti-Inflammatory Effects of

Luisa Taynara Silvério da Costa, Julia Amanda Rodrigues Fracasso, Lucas Pires Guarnier, Gustavo Reis de Brito, Daniel Baldini Fumis, Renata Aparecida de Camargo Bittencourt, Aimée Maria Guiotti, Débora de Barros Barbosa, Isabel Cristina Cherici Camargo, Edislane Barreiros de Souza and 2 more

Open access · goldAbstract read
In one paragraph

Article in Plants (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 13 citations in OpenAlex.

  1. Bioactive Potential ofPharmaceuticals (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Luisa Taynara Silvério da CostaDepartment of Biotechnology, School of Sciences and Languages, São Paulo State University (UNESP), Assis 19806-900, SP, Brazil.ORCID 0000-0002-3903-2988
Julia Amanda Rodrigues FracassoDepartment of Biotechnology, School of Sciences and Languages, São Paulo State University (UNESP), Assis 19806-900, SP, Brazil.
Lucas Pires GuarnierDepartment of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, SP, Brazil.
Gustavo Reis de BritoDepartment of Biology, School of Sciences and Languages, São Paulo State University (UNESP), Assis 19806-900, SP, Brazil.ORCID 0000-0002-5557-5501
Daniel Baldini FumisDepartament of Materials Science and Technology, Bauru School of Science, São Paulo State University (UNESP), Bauru 17033-360, SP, Brazil.
Renata Aparecida de Camargo BittencourtDepartment of Biomedicine, Institute of Health Sciences, University of São Paulo (UNIP), Assis 19813-550, SP, Brazil.
Aimée Maria GuiottiDepartment of Dental Materials and Prosthodontics, Araçatuba Dental School, São Paulo State University (UNESP), Araçatuba 16066-840, SP, Brazil.
Débora de Barros BarbosaDepartment of Dental Materials and Prosthodontics, Araçatuba Dental School, São Paulo State University (UNESP), Araçatuba 16066-840, SP, Brazil.ORCID 0000-0002-3623-5093
Isabel Cristina Cherici CamargoDepartment of Biotechnology, School of Sciences and Languages, São Paulo State University (UNESP), Assis 19806-900, SP, Brazil.
Edislane Barreiros de SouzaDepartment of Biotechnology, School of Sciences and Languages, São Paulo State University (UNESP), Assis 19806-900, SP, Brazil.
Pedro de Oliva NetoDepartment of Biotechnology, School of Sciences and Languages, São Paulo State University (UNESP), Assis 19806-900, SP, Brazil.
Lucinéia Dos SantosDepartment of Biotechnology, School of Sciences and Languages, São Paulo State University (UNESP), Assis 19806-900, SP, Brazil.
Universidade Estadual Paulista (Unesp) · BRUniversidade de São Paulo · BR

Funding

CNPq (Brazilian National Council for Scientific and Technological Development) 2016/ 39615FAPESP (São Paulo Research Foundation) 2014/14253-0
6 · The paper itself

Abstract

backgroundIn several countries, the leaf juice of Agave sisalana (also known as sisal) is widely used topically, especially as an antiseptic, and orally for the treatment of different pathologies. However, in Brazil, which is the largest producer of Agave sisalana, its residue, which represents the majority of its weight, has been thrown away. For this reason, the determination of the pharmacological and toxicological potentials of sisal residue and its possible therapeutic use is seen as a way to contribute to the sustainable development and social promotion of the largest producer of sisal in Brazil, the interior of Bahia State, which is among the poorest areas in the country. Given the scarcity of available scientific studies on the pharmacological and toxicological properties of sisal residue juice, this study aimed to promote the acid hydrolysis of this juice to potentiate the anti-inflammatory effect already described in the literature. Furthermore, it aimed to evaluate the toxicological profile of the hydrolyzed extract (EAH) and to determine its acute toxicity, as well as its side effects on the reproductive aspects of rats.

methodThe anti-inflammatory effect of EAH was evaluated in vitro using the induction of hemolysis by hypotonic solution and in vivo in rats using the carrageenan-induced paw edema test and the xylene-induced ear edema test. The acute toxicity, resulting from a single-dose administration, was investigated for some manifestation of toxic symptoms related to motor control and consciousness in rats. At a concentration of 100 mg/kg, by repeated doses, the reproductive toxicity effects of EAH in rats were assessed.

resultsIn vitro anti-inflammatory activity was positive using the human red blood cell membrane stabilization method. In both in vivo tests used to assess the anti-inflammatory activity, EAH (at three doses) significantly inhibited edema when compared to the control group. At a dose of 50 mg/kg, EAH exhibited a greater effect than indomethacin, a nonsteroidal anti-inflammatory drug with known activity. In vivo toxicological studies have shown that EAH does not present toxic effects when administered orally in a single dose, up to 1000 mg/kg. Finally, EAH promoted a gonadotoxic effect and increased the embryonic mortality rate after implantation.

conclusionsIt is suggested that the anti-edematogenic effect of the acid hydrolysis extract from sisal juice is due to the high concentration of steroidal sapogenins. Therefore, this extract can be considered a potential new anti-inflammatory or even an important sapogenin source for the development of steroidal glucocorticoids. However, further studies are needed to elucidate the chemical composition of sisal juice. Regarding toxicology studies, EAH did not show cytotoxic and clastogenic potentials, but it presented a powerful reproductive toxic effect in rats.

Indexed as

inflammationreproductive systemsapogenins

Identifiers

PMID37050149
PMCPMC10096503
OpenAlexW4362467493

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.